Investment Plan for Europe: EIB backs Italian CNS drug developer Newron Pharmaceuticals with up to EUR 40m

image_pdfimage_print

The European Commission has approved an investment package of €243 million from the EU budget for projects under the LIFE programme supporting nature, the environment and quality of life in Europe’s transition to a more sustainable and low-carbon future.